2,5-Dimethoxy-4-fluoroamphetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Trappist the monk (talk | contribs) at 15:42, 17 December 2013 (fix CS1 deprecated date parameter errors (test) using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

2,5-Dimethoxy-4-fluoroamphetamine
Clinical data
Routes of
administration
Oral, Insufflation
ATC code
  • none
Legal status
Legal status
Identifiers
  • (RS)-1-(4-fluoro-2,5-dimethoxy-phenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H16FNO2
Molar mass213.25 g/mol g·mol−1
3D model (JSmol)
  • CC(Cc1cc(c(cc1OC)F)OC)N
  • InChI=1S/C11H16FNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3 checkY
  • Key:NRANUECGGQVXOT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

2,5-Dimethoxy-4-fluoroamphetamine (DOF) is a psychedelic drug of the phenethylamine and amphetamine classes. Alexander Shulgin briefly describes DOF in his book PiHKAL:[1]

Animal studies that have compared DOF to the highly potent DOI and DOB imply that the human activity will be some four to six times less than these two heavier halide analogues.[2] As of the present time, no human trials of DOF have been made.

See also

References

  1. ^ Shulgin, Alexander (September 1991). PiHKAL: A Chemical Love Story. United States: Transform Press. p. 978. ISBN 0-9630096-0-5. {{cite book}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  2. ^ Glennon RA, Young R, Benington F, Morin RD (1982). "Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane". Journal of Medicinal Chemistry. 25 (10): 1163–8. doi:10.1021/jm00352a013. PMID 7143352. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

External links